News and Comments

OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.

  Monday, March 01, 2010

OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.  More...


Recent Postings


Archive


Tags

Inovio (INO) GUARDIAN HEALTH Anadys (ANDS) Exelixis (EXEL) Zerenex Genentech Revlimid (lenolidamide) Idenix (IDIX) Amgen (AMGN) HALOZYME (HALO) Endometrial Cancer Velcade (bortezomib) Rapamune ADVENTRIX (ANX) Bristol-Myers Squibb (BMY) Sangamo (SGMO) Onyx (ONXX) ABBVIE (ABBV) Ridaforolimus Gilead (GILD) KERYX (KERX) BIOMARIN (BMRN) ARCA (ABIO) Trastuzumab-DM1 Dendreon (DNDN) Agenus (AGEN) Mirati Therapeutics (MRTX) Sanofi (SNA) Roche (ROCHE) Abbott Laboratories (ABT) Biogen Idec (BIIB) ZALTRAP™ TOKAI (TKAOI) Prolor Biotech (PBTH) Seattle Genetics (SGEN) NEKTAR (NKTR)) Sanofi-Aventis (SAN) Sequenom (SQNM) Xoma (XOMA) Agenus (AGEN Vertex (VRTX) NANTKWEST (NK) Sarepta (SRPT) Array Pharmaceuticals (ARRY) Incyte (INCY) Alnylam (ALNY) VANDA (VNDA) galapagos (GLPG) SERES THERAPEUTICS (MCRB) Anacor (ANAC) OSI (OSIP) SUNESIS PHARMACEUTICALS (SNSS) CompuGen (CGEN) Valeant Pharmaceuticals International (VRX) Intermune (ITMN) Cytokinetics (CYTK) Illumina (ILMN) Telaprevir Theravance (THRX) SYNTA (SNTA) Micromet (MITI) Sanofi (SNY) Pluristem (PSTI) ISIS (ISIS) Human Genome Sciences (HGSI) Tysabri Dynavax (DVAX) AERIE PHARMACEUTICALS Galena (GALE) Merck (MRK) IDERA (IDRA) Intrexon (XON) Roche (RHHBY) GlaxoSmithKline (GSK) ImmunoGen (IMGN) Intercept (ICPT) Aimmune Therapeutics (AIMT) Herceptin C4 Therapeutics JUNO (JUNO) Elan (ELN) Biocryst (BCRX) Regeneron (REGN) Ariad (ARIA) Multiple Myeloma Prosensa (RNA) Auspex (ASPX) Benlysta (belimumab) Ziofpharm (ZIOP) KITE (KITE) Jazz Pharmaceuticals (JAZZ)